Phase i studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia

Simona Lapusan, Maria B. Vidriales, Xavier Thomas, Stephane De Botton, Anne Vekhoff, Ruoping Tang, Charles Dumontet, Rodica Morariu-Zamfir, John M. Lambert, Marie Laure Ozoux, Philippe Poncelet, Jesus F. San Miguel, Ollivier Legrand, Daniel J. DeAngelo, Francis J. Giles, Jean Pierre Marie*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

97 Scopus citations

Fingerprint

Dive into the research topics of 'Phase i studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science